NCT00054938View on ClinicalTrials.gov

Prevention of Atherosclerosis and Heart Disease in Patients With Systemic Lupus Erythematosis (SLE)

PHASE2CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

March 31, 2003

Primary Completion Date

December 31, 2005

Study Completion Date

December 31, 2005

Conditions
Systemic Lupus ErythematosusLupus
Interventions
DRUG

pravastatin

DRUG

aspirin

DRUG

ramipril

DRUG

Vitamins: B6, B12, and folate

BEHAVIORAL

heart health educational program

Trial Locations (1)

02115

Brigham and Women's Hospital, RBB Brigham Arthritis Center, Boston

All Listed Sponsors
collaborator

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

NIH

lead

Brigham and Women's Hospital

OTHER

NCT00054938 - Prevention of Atherosclerosis and Heart Disease in Patients With Systemic Lupus Erythematosis (SLE) | Biotech Hunter | Biotech Hunter